Pharmaceutical advertising hit a record high in 2024, with the top 10 drugs accounting for $3.3 billion in ad spending – up nearly 20% from the previous year. With more campaigns directly targeting consumers, MedBen Rx’s high-value formulary educates members about medications that offer real clinical value rather than just commercial appeal.
Drugmakers encourage patients to request specific drugs by name – often newer, more expensive medications that aren’t necessarily better than current therapies. Without access to reliable, unbiased information, many patients take advertising at face value, assuming that high cost equals high quality.
MedBen Rx takes a smarter approach with its high-value formulary, which uses evidence-based research to identify drugs proven to deliver the best outcomes. And as new drugs come on the market, we continually reevaluate recommendations to ensure clients stay on the most cost-effective, high-impact treatment path.
Want to learn how a high-value formulary can lower your costs while improving member care? Contact your broker or MedBen Marketing to start the conversation.